T cell major histocompatibility complex class II molecules down-regulate CD4+ T cell clone responses following LAG-3 binding
- PMID: 8647185
- DOI: 10.1002/eji.1830260533
T cell major histocompatibility complex class II molecules down-regulate CD4+ T cell clone responses following LAG-3 binding
Abstract
T cell response to its antigen requires recognition by the T cell receptor together with a co-receptor molecule, either CD4 or CD8. Additional molecules have been identified that are capable of delivering the co-stimulatory signals provided by APC. Following T cell priming, a number of T cell activation antigens are expressed that may play a role in the inactivation phase of the T cell response. The lymphocyte activation gene (LAG)-3 protein and its counter-receptors, the major histocompatibility complex (MHC) class II molecules, are such activation antigens whose interaction may result in the down-regulation of the ongoing immune response. To investigate the role of LAG-3/class II molecule interaction, we produced a soluble form of LAG-3 by fusing the extracellular Ig domains of this membrane protein to the constant region of human IgG1 (LAG-3Ig). Here, we show a direct and specific binding of LAG-3Ig to class II molecules on the cell surface. In addition, we show that LAG-3/class II molecule interaction leads to the down-regulation of CD4+ Ag-specific T cell clone proliferation and cytokine secretion. This inhibitory effect is observed at the level of the effector cells and not the APC and is also found with anti-CD3 mAb, PHA + PMA or low-dose IL-2 driven stimulation in the absence of APC. These functional studies indicate that T cell MHC class II molecules down-regulate T cell proliferation following LAG-3 binding and suggest a role for LAG-3 in the control of the CD4+ T cell response.
Similar articles
-
CD4/major histocompatibility complex class II interaction analyzed with CD4- and lymphocyte activation gene-3 (LAG-3)-Ig fusion proteins.Eur J Immunol. 1995 Sep;25(9):2718-21. doi: 10.1002/eji.1830250949. Eur J Immunol. 1995. PMID: 7589152
-
Lymphocyte-activation gene 3/major histocompatibility complex class II interaction modulates the antigenic response of CD4+ T lymphocytes.Eur J Immunol. 1994 Dec;24(12):3216-21. doi: 10.1002/eji.1830241246. Eur J Immunol. 1994. PMID: 7805750
-
T Lymphocytes infiltrating various tumour types express the MHC class II ligand lymphocyte activation gene-3 (LAG-3): role of LAG-3/MHC class II interactions in cell-cell contacts.Eur J Cancer. 2001 Sep;37(13):1709-18. doi: 10.1016/s0959-8049(01)00184-8. Eur J Cancer. 2001. PMID: 11527700
-
Immune recognition and effector function in subsets of CD4 T cells.Princess Takamatsu Symp. 1988;19:193-208. Princess Takamatsu Symp. 1988. PMID: 2908353 Review.
-
CD4 and CD8 recognition of class II and class I molecules of the major histocompatibility complex.Semin Immunol. 1991 May;3(3):177-85. Semin Immunol. 1991. PMID: 1909595 Review.
Cited by
-
Immunotherapy in endometrial cancer: rationale, practice and perspectives.Biomark Res. 2021 Jun 16;9(1):49. doi: 10.1186/s40364-021-00301-z. Biomark Res. 2021. PMID: 34134781 Free PMC article. Review.
-
Lymphocyte-activation gene-3, an important immune checkpoint in cancer.Cancer Sci. 2016 Sep;107(9):1193-7. doi: 10.1111/cas.12986. Epub 2016 Aug 25. Cancer Sci. 2016. PMID: 27297395 Free PMC article. Review.
-
Perspectives on the role of breast cancer susceptibility gene in breast cancer.Int J Clin Oncol. 2022 Mar;27(3):495-511. doi: 10.1007/s10147-021-02098-1. Epub 2022 Jan 22. Int J Clin Oncol. 2022. PMID: 35064849
-
Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy.J Hematol Oncol. 2023 Sep 5;16(1):101. doi: 10.1186/s13045-023-01499-1. J Hematol Oncol. 2023. PMID: 37670328 Free PMC article. Review.
-
Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3.Cell. 2019 Jan 10;176(1-2):334-347.e12. doi: 10.1016/j.cell.2018.11.010. Epub 2018 Dec 20. Cell. 2019. PMID: 30580966 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials